The Oncology Institute, Inc.
TOI
$4.59
$0.122.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -43.51M | -60.61M | -66.28M | -65.89M | -64.36M |
| Total Depreciation and Amortization | 6.78M | 6.94M | 7.02M | 6.87M | 6.58M |
| Total Amortization of Deferred Charges | 4.72M | 8.38M | 8.77M | 9.18M | 9.62M |
| Total Other Non-Cash Items | 11.08M | 19.37M | 20.45M | 15.61M | 8.59M |
| Change in Net Operating Assets | -876.00K | 1.33M | 6.41M | 24.04M | 23.92M |
| Cash from Operations | -21.81M | -24.59M | -23.63M | -10.19M | -15.64M |
| Capital Expenditure | -3.91M | -3.20M | -3.90M | -2.89M | -3.51M |
| Sale of Property, Plant, and Equipment | 0.00 | 126.00K | 126.00K | 126.00K | 126.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 10.00M | 30.00M |
| Cash from Investing | -3.91M | -3.07M | -3.77M | 7.24M | 26.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.06M | -21.03M | -20.88M | -20.65M | -20.42M |
| Issuance of Common Stock | 17.38M | 32.64M | 28.54M | 17.70M | 15.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | -50.00K | 0.00 | -232.00K | -2.37M |
| Cash from Financing | 16.27M | 11.56M | 7.66M | -3.18M | -7.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.46M | -16.10M | -19.74M | -6.13M | 3.68M |